HeLa cells are a human epithelial cervical cancer (cervical cancer), and the first human cells, from which a permanent cell line was established. On 9 February 1951, surgeon Lawrence Wharton Jr. removed the tissue from the patient Henrietta Lacks, a 31-year-old African American woman from Baltimore, in the Women's Clinic of the Johns Hopkins Hospital. The cells were from the carcinoma of the cervix and were expected to be examined for malignancy. The patient died 8 months later from the disease.
A portion of cells from the biopsy were sent to George Gey, the then head of the cell culture laboratory at Johns Hopkins Hospital. The cells were cultivated and propagated in cell culture so well that since they are widely used in research. The HeLa cells were used in the establishment of the first polio vaccine by Jonas Salk. HeLa cells are now available in many laboratories of the world. The worldwide sale of HeLa cells suggests that Ms. Lacks is probably the "most valuable" human individual had previously lived.
Henrietta's Dance: story of Henrietta Lacks and the battle of survival
The Term HeLa: HeLa term is used in conjunction with the word cell and used in the literature of the biological and medical topics. This line of cells that are derived from cancer cells taken from the patient named Henrietta Lacks, died from cancer in 1951. HeLa cell line are today used to study cancer.
HeLa cells 50 years on: the good, the bad and the ugly. Nature report
HelaCells.com
Designed by singh
Where did the HeLa cells come from?
